MediPrint Ophthalmics
PrivateLast Round
Series A
Mar 15, 2022
Total Funding Raised
$6.5M
Company Overview
MediPrint Ophthalmics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in March 2022.
MediPrint Ophthalmics is a clinical-stage pharmaceutical company developing a proprietary ocular drug delivery portfolio using drug-eluting contact lenses to treat conditions like glaucoma, dry eye, and allergies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediPrint Ophthalmics Comparables
Compare MediPrint Ophthalmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Freya Ophthalmics | 89% | |
| OcuMedic, Inc. | 84% | |
| Mati Therapeutics | 81% |
For institutional investors. Book with your work email.
MediPrint Ophthalmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2022 | ||||
| Seed | Jan 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Monthly visitors increased 1050% MoM, from 34 to 391.
- Oct 29, 2024
Monthly visitors grew 337% MoM.
For institutional investors. Book with your work email.
MediPrint Ophthalmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MediPrint Ophthalmics's valuation, stock price, and market status.
Is MediPrint Ophthalmics a public or private company?
MediPrint Ophthalmics is a private company.
What is the current stock price of MediPrint Ophthalmics?
MediPrint Ophthalmics is a private company, so its shares have no public market price. Caplight tracks MediPrint Ophthalmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MediPrint Ophthalmics worth (valuation)?
Valuation information for MediPrint Ophthalmics is not publicly available.
Can I buy MediPrint Ophthalmics stock?
MediPrint Ophthalmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MediPrint Ophthalmics's last funding round?
MediPrint Ophthalmics's most recent funding round was Series A on March 15, 2022.
Who are the main investors in MediPrint Ophthalmics?
Investor information for MediPrint Ophthalmics is not publicly disclosed.
Will MediPrint Ophthalmics IPO soon?
No public IPO plans have been announced for MediPrint Ophthalmics.
How can I track MediPrint Ophthalmics secondary market activity?
Caplight tracks bids, offers, and trades in MediPrint Ophthalmics's shares on secondary markets.